• 1
    Simonetti RG, Camma C, Firelo F, Politi F, D’Amico G, Pagliaro L. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991; 36: 96272.
  • 2
    Tsuda H, Oda T, Sakamoto M, Hirohashi S. Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin. Cancer Res 1992; 52: 15049.
  • 3
    Nagasue N, Uchida M, Makino Y et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 48894.
  • 4
    Takenaka K, Adachi E, Nishizaki T et al. Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study. Hepatology 1994; 19: 88994.
  • 5
    Kumada T, Nakano S, Takeda I et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997; 25: 8792.
  • 6
    Saito I, Miyamura T, Ohbayashi A et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 65479.
  • 7
    Tanaka K, Hirohata T, Koga S et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cance Res 1991; 51: 28427.
  • 8
    Qian GS, Ross RK, Yu MC et al. A following-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994; 3: 310.
  • 9
    Tsujiuchi T, Tsutsumoto M, Sasaki Y, Takahama M, Konishi Y. Different frequencies and patterns of β-catenin mutations in hepatocellular carcinomas induced by N-nitrosodiethylamine and a choline-deficient 1-amino acid-defined diet in rats. Cancer Res 1999; 59: 39047.
  • 10
    Tsujiuchi T, Sasaki Y, Kubozoe T, Tsutsumoto M, Konishi Y, Nakae D. Alterations of the Fhit gene in hepatocellular carcinomas induced by N-nitrosodiethylamine in rats. Mol Carcinog 2002; 34: 1924.
  • 11
    Sasaki Y, Tsujiuchi T, Murata N, Tsutsumoto M, Konishi Y, Nakae D. Alterations of the transforming growth factor-β signaling pathway in hepatocellular carcinomas induced endogenously and exogenously in rats. Jpn J Cancer Res 2001; 92: 1622.
  • 12
    Murakami Y, Nobukuni T, Tamura K et al. Localization of tumor suppressor activity important in non-small cell lung carcinoma on chromosome 11q. Proc Natl Acad Sci USA 1998; 95: 81538.
  • 13
    Kuramochi M, Fukuhara H, Nobukuni T et al. TSLC1 is a tumor suppressor gene in human non-small-cell lung cancer. Nat Genet 2001; 27: 42730.
  • 14
    Gomyo H, Arai Y, Tanigami A et al. A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2. Genomics 1999; 62: 13946.
  • 15
    Tran YK, Bogler O, Gorse KM, Wieland I, Green MR, Newsham IF. A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer. Cancer Res 1999; 59: 3543.
  • 16
    Yageta M, Kuramochi M, Masuda M et al. Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins, in lung cancer. Cancer Res 2002; 62: 512933.
  • 17
    Murakami Y. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer. Oncogene 2002; 21: 693648.
  • 18
    Fukami F, Fukuhara H, Kuramochi M et al. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines. Int J Cancer 2003; 107: 539.
  • 19
    Fukuhara H, Kuramochi M, Fukumi T et al. Promoter methylation of the TSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res 2002; 93: 6059.
  • 20
    Jansen M, Fukushima N, Rosty C et al. Aberrant methylation of the 5′-CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs. Cancer Biol Ther 2002; 1: 2936.
  • 21
    Kikuchi S, Yamada D, Fukami T et al. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer. Clin Cancer Res 2005; 11: 295461.
  • 22
    Heller G, Fong KM, Girard L et al. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas. Oncogene 2006; 25: 95968.
  • 23
    Yamada D, Kikuchi S, Williams YN et al. Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma. Int J Cancer 2006; 118: 91623.
  • 24
    Shimizu K, Itsuzaki Y, Onishi M, Fujii H, Honoki K, Tsujiuchi T. Reduced expression of the Tslc1 gene and its aberrant DNA methylation in rat lung tumors. Biochem Biophys Res Commun 2006; 347: 35862.
  • 25
    Higgins GM, Anderson RM. Experimental pathology of the liver. 1. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol Lab Med 1931; 12: 1186202.
  • 26
    Cayama E, Tsuda H, Sarma DSR, Farber E. Initiation of chemical carcinogenesis requires cell proliferation. Nature (Lond) 1978; 275: 602.
  • 27
    Tsuda H, Lee G, Farber E. Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Cancer Res 1980; 40: 115764.
  • 28
    Ohashi K, Tsutsumi M, Tsujiuchi T et al. Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis caused by a colchicines-induced cell cycle disturbance in partially hepatectomized rats. Cancer Res 1996; 56: 34739.
  • 29
    Tsutsumi M, Ohashi K, Tsujiuchi T et al. Disturbance of the cell cycle with colchicine enhances the growth advantage of diethylnitrosamine-initiated hepatocytes in rats. Jpn J Cancer Res 1996; 87: 59.
  • 30
    Shimizu K, Kato A, Hinotsume D et al. Reduced expressions of Foxp1 and Rassfla genes in lung adenocarcinomas induced by N-nitrosobis (2-hydroxypropyl) amine in rats. Cancer Lett 2006; 236: 18690.
  • 31
    Shimizu K, Kato A, Shigemura M, Fujii H, Honoki H, Tsujiuchi T. Aberrant methylation patterns of the Rassfla gene in rat lung adenocarcinomas induced by N-nitrosobis (2-hydroxypropyl) amine. Mol Carcinog 2006; 45: 11217.
  • 32
    Uchino K, Ito A, Wakayama T et al. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung. Cancer 2003; 98: 10027.
  • 33
    Fukushima N, Morita Y. Actomysin-dependent microtubule rearrangement in lysophosphatidic acid-induced neurite remodeling of young cortical neurons. Brain Res 2006; 1094: 6575.
  • 34
    Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 2003; 94: 57581.
  • 35
    Mao X, Seidlitz E, Ghosh K, Murakami Y, Ghosh HP. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer. Cancer Res 2003; 63: 797985.
  • 36
    Mao X, Seidlitz E, Truant R, Hitt M, Ghosh HP. Re-expression of TSLC1 in a non-small-cell lung cancer cell line induced apoptosis and inhibits tumor growth. Oncogene 2004; 23: 563242.
  • 37
    Charboneau AL, Singh VYuT, Newsham IF. Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells. Int J Cancer 2002; 100: 1818.
  • 38
    Jiang W, Newsham IF. The tumor suppressor DAL-1/4.1B and protein methylation cooperate in inducing apoptosis in MCF-7 breast cancer cells. Mol Cancer 2006; 5: 4.
  • 39
    Tsujiuchi T, Masaoka T, Sugata E et al. Hypermethylation of the Dal-1 gene in lung adenocarcinomas induced by N-nitrosobis (2-hydroxypropyl) amine in rats. Mol Carcinog 2007 (in press).
  • 40
    Nakae D, Yoshiji H, Mizumoto Y et al. High incidence of hepatocellular carcinomas induced by a choline deficient 1-amino acid defined diet in rats. Cancer Res 1992; 52: 50425.